Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 5,686 shares at $35.54 ($202K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Scheduled sale ($202k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.54 | 1,137 | $40K | 20.0% |
| 2 | $35.54 | 1,187 | $42K | 20.9% |
| 3 | $35.54 | 1,681 | $60K | 29.6% |
| 4 | $35.54 | 1,681 | $60K | 29.6% |
| Total | $35.54 avg | 5,686 | $202K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |